Inductive Bio: Valuation, Funding & Investors
Inductive Bio is a technology company focused on democratizing artificial intelligence (AI) models to revolutionize small molecule drug discovery. By leveraging state-of-the-art AI trained on pre-competitive datasets, the company aims to accelerate the development of life-saving therapies.
Leadership & Board
- Current Number of Employees
- 42
- Current LinkedIn Followers
- 5,050
Latest Estimated Valuation
- Total Amount Raised
- $25M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $25M
- Latest Funding Round
- Series A
Company Momentum
PositiveInductive Bio LinkedIn following is increasing, signaling rising market interest, while its workforce is growing, indicating business expansion.
Employee Trend
Inductive Bio had 42 employees as of November 9, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
Inductive Bio had 5,050 followers as of November 9, 2026. The number of followers increased by 56 (1.12%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| May 07, 2025 | Series A | $25.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Obvious Ventures | Series A |
| Lux Capital | Series A |
| S32 | Series A |
| Andreessen Horowitz | Series A |
| Character | Series A |
| Amino Collective | Series A |
| Oren Etzioni | Series A |
| Jeff Hammerbacher | Series A |
Similar Companies
A snapshot of private companies similar to Inductive Bio, helping you discover and navigate related company profiles.









